About this trial

The study focuses the mechanisms underlying the loss of intestinal homeostasis in celiac disease, refractory celiac disease and other immune diseases such as monogenic enteropathy, inflammatory bowel diseases or drug induced intestinal diseases. Mechanisms of transformation of lymphocytes leading to onset of lymphomatous complications of immune enteropathies will be investigated. Mechanisms of loss of hepatic lymphocytic homeostasis will also be assessed in liver associated diseases.

Eligibility criteria

Qualifiers

18 years or over

affiliated to social insurance

signed informed consent

Disqualifiers

pregnancy

under guardianship

not able to sign informed consent

Trial design

Treatments tested in this trial

  • Blood sample collection; gastrointestinal biopsy

Treatment groups

200 Participants
are divided into 7 treatment groups

7

Treatment groups

See each treatment group below.

Locations

4
Hôpital Henri Mondor94010, Créteil France
Hôpital Bicêtre94270, Le Kremlin-Bicêtre France
Hôpital Cochin75014, Paris France
Hôpital Saint Louis75010, Paris France

Sponsors and collaborators

Institut National de la Santé Et de la Recherche Médicale, France

Lead sponsor

Imagine Institute

Collaborator